In last trading session, ABVC BioPharma Inc (NASDAQ:ABVC) saw 0.47 million shares changing hands with its beta currently measuring 0.13. Company’s recent per share price level of $1.48 trading at $0.27 or 22.31% at ring of the bell on the day assigns it a market valuation of $24.83M. That closing price of ABVC’s stock is at a discount of -20.95% from its 52-week high price of $1.79 and is indicating a premium of 72.97% from its 52-week low price of $0.40. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.35 million shares which gives us an average trading volume of 715.54K if we extend that period to 3-months.
For ABVC BioPharma Inc (ABVC), analysts’ consensus is at an average recommendation of Hold while assigning it a mean rating of 3.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 1 suggested the stock as a Hold whereas 0 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of 0 in the current quarter.
ABVC BioPharma Inc (NASDAQ:ABVC) trade information
Upright in the green during last session for gaining 22.31%, in the last five days ABVC remained trading in the green while hitting it’s week-highest on Wednesday, 05/14/25 when the stock touched $1.48 price level, adding 17.32% to its value on the day. ABVC BioPharma Inc’s shares saw a change of 150.85% in year-to-date performance and have moved 22.31% in past 5-day. ABVC BioPharma Inc (NASDAQ:ABVC) showed a performance of 52.58% in past 30-days. Number of shares sold short was 0.32 million shares which calculate 0.52 days to cover the short interests.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 27.39% during past 5 years.
ABVC BioPharma Inc (NASDAQ:ABVC)’s Major holders
Insiders are in possession of 16.47% of company’s total shares while institution are holding 2.28 percent of that, with stock having share float percentage of 2.73%. Investors also watch the number of corporate investors in a company very closely, which is 2.28% institutions for ABVC BioPharma Inc that are currently holding shares of the company.
On the other hand, Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Mar 31, 2025 , the former fund manager was holding 59.67 shares of worth $88307.0 or 0.36% of the total outstanding shares. The later fund manager was in possession of 46.95 shares on Dec 31, 2024 , making its stake of worth around $69481.0 in the company or a holder of 0.28% of company’s stock.
